Elizabeth Garrett-Mayer, Ph.D.

Dr. Garrett-Mayer joined ASCO in 2017 as CENTRA’s Division Director for Biostatistics and Research Data Governance and became CENTRA’s first Vice President in 2022. CENTRA leads ASCO’s research efforts, including the TAPUR Study, ASCO’s COVID-19 Registry, and research projects aimed at dose optimization and increasing minority enrollment in clinical trials. Prior to joining ASCO, she served on the faculty in the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in the Department of Oncology, and then joined the faculty of the Medical University of South Carolina (MUSC) and established the Biostatistics Shared Resource at the Hollings Cancer Center (HCC). 

She earned her bachelor’s degree from Bowdoin College in Math and Economics, and a PhD in Biostatistics from Johns Hopkins Bloomberg School of Public Health. During her time at Johns Hopkins and MUSC, she taught courses in biostatistics and public health science, and mentored pre- and post-doctoral students.  Her publication record includes more than 300 peer-reviewed publications, primarily in early phase clinical trial design methods and clinical cancer research. She has been a member of numerous NIH grant review committees, NCI task forces and steering groups, Data Safety Monitoring Boards for NIH-supported clinical trials, serves on the editorial board of three peer-reviewed journals (Clinical Trials, Cancer, and the Journal of the National Cancer Institute), and was faculty on the ASCO/AACR Methods in Clinical Cancer Research Workshop for over a decade.